Evolving Role of Non‐Statin Therapy for the Management of Dyslipidemia and Cardiovascular Risk Reduction: Past, Present, and Future

Publisher： John Wiley & Sons Inc

E-ISSN： 1875-9114|38|2|164-171

ISSN： 0277-0008

Source： PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol.38, Iss.2, 2018-02, pp. : 164-171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Cardiovascular risk and lipid management beyond statin therapy: the potential role of omega-3 polyunsaturated fatty acid ethyl esters

By Halcox Julian P

Clinical Lipidology, Vol. 8, Iss. 3, 2013-06 ,pp. : 329-344

Future Medicine

Access to resources Recommend Favorite

Evolving role of FNA biopsy in diagnosing lymphoma: Past, present, and future

CANCER CYTOPATHOLOGY, Vol. 123, Iss. 7, 2015-07 ,pp. : 389-393

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cardiovascular Proteomics: Past, Present, and Future

By White Melanie Y. Van Eyk Jennifer E.

Molecular Diagnosis & Therapy, Vol. 11, Iss. 2, 2007-01 ,pp. : 83-95

Adis International

Access to resources Recommend Favorite

Prediction of cardiovascular event risk reduction from lipid changes associated with high potency dyslipidemia therapy

By Charland Scott L. Malone Daniel C.

Current Medical Research and Opinion, Vol. 26, Iss. 2, 2010-02 ,pp. : 365-375

Informa Healthcare

Access to resources Recommend Favorite

Hyperglycemia, dyslipidemia and hypertension in older people with diabetes: the benefits of cardiovascular risk reduction

By Brown Siobhan HM Abdelhafiz Ahmed H

Therapy, Vol. 6, Iss. 4, 2009-07 ,pp. : 515-529

Future Medicine

Access to resources Recommend Favorite